<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03153748</url>
  </required_header>
  <id_info>
    <org_study_id>CHEC2017-074</org_study_id>
    <nct_id>NCT03153748</nct_id>
  </id_info>
  <brief_title>New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population</brief_title>
  <acronym>NATIONAL-2</acronym>
  <official_title>New Therapeutic System of Ruptured Intracranial Aneurysms Based on Big Data From Chinese Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at clarifying the current situation of Emergency treatment of aneurysmal
      subarachnoid hemorrhage (SAH) in China, and analyzing the safety and efficacy of the
      treatment strategy between interventional treatment and open surgery, so as to improve the
      diagnosis and treatment of aneurysmal SAH.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>mRS score</measure>
    <time_frame>1 year after treatment</time_frame>
    <description>the mRS score after treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cure rate</measure>
    <time_frame>6 months after treatment</time_frame>
    <description>the proportion of the cured-patient according Raymond Class</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>recurrence rate</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>the proportion of the recurrence of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>the proportion of complication happened after treatment including ischemic, hemorrhage, retreat, and so on</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Subarachnoid Hemorrhage, Aneurysmal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients presented with subarachnoid hemorrhage and diagnosed with ruptured aneurysm at all
        age.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients presented with subarachnoid hemorrhage on CT or lumbar puncture.

          -  the intracranial hemorrhage was caused by rupture of aneurysm and was confirmed on
             CTA、MRA or DSA.

          -  patients willing to participate in this clinical trial and attach to regular follow
             up.

        Exclusion Criteria:

          -  intracranial aneurysm correlating to AVM.

          -  dissection, false, traumatic and infectious aneurysms.

          -  the rupture of the aneurysm can not be confirmed on CTA、MRA or DSA.

          -  patients unwilling to participate in this clinical trial and attach to regular follow
             up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qinghai Huang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changhai Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pengfei Yang, MD</last_name>
    <phone>+86 15921196312</phone>
    <email>15921196312@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hongjian Zhang, MD</last_name>
    <phone>+86 13961616656</phone>
    <email>chzhanghj2012@me.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pengfei Yang, MD</last_name>
      <phone>+86 15921196312</phone>
      <email>15921196312@me.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Qinghai Huang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Treatment strategy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

